Author

Svitlana Postol

Observed name: Postol, Svitlana

Observed institution: Sanofi (United States)

OpenAlex ID: A5092860610

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

2023 · Gustavo H Dayan, Nadine Rouphael, et al. · The Lancet Respiratory Medicine · 25

Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis

2024 · Jean-Yves Reginster, Edward Czerwinski, et al. · Osteoporosis International · 17

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data

2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 6

Iodine insufficiency as a dietary issue in elderly people and its connection with pathology of thyroid

2016 · Simurova, Natalia, Postol, Svitlana, et al. · Institutional Repository of National University of Food Technologies

Works count: 5

Citation count: 48

H-index: 3

I10-index: 2